Active Ingredient(s): Atazanavir + Cobicistat
FDA Approved: * January 29, 2015
Category: HIV / AIDS

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Evotaz Overview

Atazanavir, sold under the brand name Reyataz among others, is an antiretroviral medication used to treat HIV/AIDS.[2] It is generally recommended for use with other antiretrovirals.[2] It may be used for prevention after a needlestick injury or other potential exposure (postexposure prophylaxis (PEP)).[2] It is taken by mouth once a day.[2] Common side effects include headache, nausea, yellowish skin, abdominal pain, trouble sle...

Read more Evotaz Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Atazanavir

Recent Evotaz Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Atazanavir + Cobicistat
  • Tablet: 300 + 150mg, 300mg + 150mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Evotaz: (3 results)

Sorted by National Drug Code
  • 0003-3641 Evotaz Oral Tablet by E.r. Squibb & Sons, L.L.C.
  • 50090-1724 Evotaz Oral Tablet by A-s Medication Solutions
  • 54569-6595 Evotaz Oral Tablet by A-s Medication Solutions

Drugs with one or more similar ingredients: (12 results)